Valeant Pharmaceuticals International Inc., Canada's biggest publicly traded drugmaker, reported a 12-percent rise in adjusted quarterly profit due to higher product sales and raised its full-year... Bhaswati Mukhopadhyay, Reuters Posted on 5-02-2013 at 8:57 AM Tags: Valeant Pharmaceuticals, Pharmaceuticals
Canadian pharmacy chain Jean Coutu Group Inc.'s fourth-quarter profit missed analysts' expectations as tighter price controls for generic drugs hit revenue. Krithika Krishnamurthy, Reuters Posted on 5-01-2013 at 8:13 AM Tags: Jean Coutu, Pharmaceuticals
Merck & Co Inc. reported disappointing first-quarter sales on a surprising downturn for its Januvia diabetes medicine, the company's biggest product and usual earnings driver, and the... Ransdell Pierson, Reuters Posted on 5-01-2013 at 11:02 AM Tags: Merck & Co, Pharmaceuticals
A proposed merger of Valeant Pharmaceuticals International Inc. and Actavis Inc. was put on hold after the two drugmakers failed to agree on terms of a deal that would have created a healthcare... Reuters Posted on 4-29-2013 at 8:16 AM Tags: Valeant Pharmaceuticals, Pharmaceuticals
Germany's Merz Pharma Group withdrew its offer for U.S. cosmetic products maker Obagi Medical Products Inc., after rival bidder Canada's Valeant Pharmaceuticals International Inc. raised its offer... Esha Dey, Reuters Posted on 4-08-2013 at 12:30 PM Tags: Valeant Pharmaceuticals, Pharmaceuticals
Valeant Pharmaceuticals International Inc. raised its offer for cosmetics products maker Obagi Medical Products Inc. to $24 per share US, a day after its initial bid was topped by German drugmaker... Esha Dey, Reuters Posted on 4-03-2013 at 9:48 AM Tags: Pharmaceuticals, Valeant Pharmaceuticals
India's top court dismissed Swiss drugmaker Novartis AG's attempt to win patent protection for its cancer drug Glivec, a blow to Western pharmaceutical firms targeting India to drive sales and a... Kaustubh Kulkarni and Suchitra Mohanty, Reuters Posted on 4-01-2013 at 9:42 AM Tags: Novartis, India, Pharmaceuticals, Patents
INSIDE THE CHASE: You know you’re going to ruffle a few feathers when you give the title Bad Pharma to your latest book alleging how the pharmaceutical industry misleads both doctors and consumers,... Zena Olijnyk, BNN chase producer Posted on 2-22-2013 at 5:33 PM Tags: Pharmaceuticals
Valeant Pharmaceuticals International Inc., already Canada's biggest listed drugmaker, could double or quadruple revenue "in the foreseeable future," the company's chief executive said on Friday. Reuters Posted on 1-04-2013 at 9:38 AM Tags: Valeant Pharmaceuticals, Pharmaceuticals
Gilead Sciences Inc will buy Canada's YM BioSciences Inc for about $465 million US in cash to gain access to its experimental blood and immune cell disorder drug. Adithya Venkatesan and Shounak Dasgupta, Reuters Posted on 12-12-2012 at 10:24 AM Tags: Gilead Sciences, Pharmaceuticals